Your browser doesn't support javascript.
loading
Anti-PD1-Induced Immune-Related Adverse Events and Survival Outcomes in Advanced Melanoma.
Suo, Aleksi; Chan, Yin; Beaulieu, Carissa; Kong, Shiying; Cheung, Winson Y; Monzon, Jose G; Smylie, Michael; Walker, John; Morris, Don; Cheng, Tina.
  • Suo A; Department of Oncology, University of Calgary, Calgary, Alberta, Canada.
  • Chan Y; Department of Gastroenterology, University of Calgary, Calgary, Alberta, Canada.
  • Beaulieu C; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
  • Kong S; Department of Oncology, University of Calgary, Calgary, Alberta, Canada.
  • Cheung WY; Department of Oncology, University of Calgary, Calgary, Alberta, Canada.
  • Monzon JG; Department of Oncology, University of Calgary, Calgary, Alberta, Canada.
  • Smylie M; Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada.
  • Walker J; Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada.
  • Morris D; Department of Oncology, University of Calgary, Calgary, Alberta, Canada.
  • Cheng T; Translational Cancer Laboratories, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada.
Oncologist ; 25(5): 438-446, 2020 05.
Article en En | MEDLINE | ID: mdl-32048768
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antineoplásicos Inmunológicos / Melanoma Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antineoplásicos Inmunológicos / Melanoma Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article